The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
2 May 2020
Employment effect (start)
15 May 2020
Foreseen end date
31 December 2020
Description
The manufacturer of rapid diagnostic testing, Biosynex, has decided to reshore part of the assembly of its COVID-19 screening tests to its Illkirch-Graffenstaden site (Bas-Rhin). The company has started to hire and is planning to recruit around 100 employees. Initially, the tests will be assembled manually, then the process will become more automated and by the end of the summer the site will be 'as competitive as the Chinese', said the president of Biosynex. The company has already signed a purchase agreement for a manufacturing robot, which alone will produce one million tests per month. China will still continue to supply the raw material (the production of antibodies, which is the heart of the system).
A second production site is due to start up in Lyon. In addition, Biosynex hopes in the long term to be able to produce nearly 5 million tests per month. Local test production will also avoid the logistical bottlenecks that the company has experienced, which have caused many delays in the delivery of tests to France.
Eurofound (2020), Biosynex, Reshoring in France, factsheet number 100603, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/100603.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...